Marvell gives Google option to buy $12.2 billion stake in custom chip deal
Reuters2026/08/19 12:46Adds shares in paragraph 2; details and background throughout
Aug 19 (Reuters) - Marvell Technology MRVL.O said on Wednesday it has issued Alphabet's Google GOOGL.O a warrant to buy a stake worth about $12.18 billion as part of a deal to help develop custom chips for the search giant.
Shares of the custom chipmaker jumped more than 11% in premarket trading, while larger rival Broadcom AVGO.O was down over 3%.
Demand for custom chips such as Google's tensor processing units (TPUs), used for AI workloads, has surged in recent years as businesses seek alternatives to Nvidia's NVDA.O pricey graphics processors.
Marvell said it would develop AI inference accelerators, storage, networking and memory interface controllers and near-memory computing technologies for Google.
In April, Broadcom signed a long-term agreement with Google to develop and supply future generations of custom AI chips and other components for the company's next-generation AI racks through 2031.
(Reporting by Anhata Rooprai in Bengaluru; Editing by Shilpi Majumdar)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Cambria Gold Mines FY26 Q2 net loss narrows to CAD 2.96 million
TRUMP rises nearly 8% in 24 hours, market capitalization reaches $2.037 billions
Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.
Electra Therapeutics Inc. has officially filed for an initial public offering (IPO), aiming to leverage the strong IPO performance of the biotechnology sector this year to raise funds for its clinical-stage pipeline of drugs targeting immune-mediated diseases and cancer.
Crypto prices
More
